Building Scalable, Reliable AAV Gene Therapy Manufacturing
Emmanuel Abate discusses how FDA's AMT designation and platform-based manufacturing can enhance the scalability and quality of AAV gene therapies.

Read More
Categories
© Copyright SynBioBeta
2026








